Navigation Links
KV Pharmaceutical Receives Report From Inspector of Elections Certifying Votes to Approve Appointment of Director
Date:1/16/2010

product introductions result in litigation, agency action or material damages;
  • the satisfaction or waiver of the other closing conditions in the previously disclosed Gestiva(TM) acquisition agreement;
  • the series of putative class action lawsuits alleging violations of the federal securities laws by the Company and certain individuals, all as more fully described in the Company's Form 8-K filed with the SEC on January 26, 2009, the Company's Form 8-K filed with the SEC on February 26, 2009, the Company's Form 8-K filed with the SEC on April 30, 2009, as well as certain other of the Company's SEC filings;
  • the possibility that insurance proceeds are insufficient to cover potential losses that may arise from litigation, including with respect to product liability or securities litigation;
  • the informal inquiry initiated by the SEC and any related or additional governmental investigative or enforcement proceedings, including actions by the FDA and the U.S. Department of Justice, all as more fully described in the Company's Form 8-K filed with the SEC on January 26, 2009, the Company's Form 8-K filed with the SEC on February 26, 2009, the Company's Form 8-K filed with the SEC on April 30, 2009, the Company's Form 8-K filed with the SEC on July 24, 2009 and the Company's Form 8-K filed with the SEC on November 12, 2009;
  • delays in returning, or failure to return, certain or many of the Company's approved products to market, including loss of market share as a result of the suspension of shipments, and related costs;
  • the ability to sell or license certain assets, and the terms of such transactions;
  • the possibility that the auction rate securities held by the Company may not return to liquidity at or near their face value;
  • the ability to monetize the auction rate securities currently held by the Company, the amount of proceeds to be received from such monetization and the timing of receipt of proceeds by t
    '/>"/>

  • SOURCE KV Pharmaceutical Company
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related medicine technology :

    1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
    2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
    3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
    4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
    5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
    6. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
    7. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
    8. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
    9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
    10. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
    11. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:3/5/2015)... und TÜBINGEN, Deutschland, 5. März 2015 ... Stiftung und das deutsche biopharmazeutische Unternehmen CureVac ... Millionen Euro (52 Millionen US-Dollar) in CureVac ... der medizinisch angewandten Messenger-RNA (mRNA). Auf Basis ... zur Behandlung von Krankheiten und zum Schutz ...
    (Date:3/5/2015)... , March 5, 2015  BioPhotas, Inc., an FDA ... use patented photo-therapeutic technologies to treat skin, muscle and ... the Semper Fi Fund to provide BioPhotas, flagship product, ... of pain management solutions.  Commenting on ... Marine who used the Celluma at the Warrior Hope ...
    (Date:3/5/2015)... , March 5, 2015  Sanomedics, Inc. (OTC: SIMH, ... company focused on developing, manufacturing, and acquiring cutting-edge technology, ... Thermomedics, Inc., will be exhibiting at booth # 709 ... Conference (NAPNAP) taking place on March 11-13, 2015 ... The 36 th ...
    Breaking Medicine Technology:Bill & Melinda Gates Stiftung investiert in CureVac zur Entwicklung innovativer Impfstoffe 2Bill & Melinda Gates Stiftung investiert in CureVac zur Entwicklung innovativer Impfstoffe 3Bill & Melinda Gates Stiftung investiert in CureVac zur Entwicklung innovativer Impfstoffe 4BioPhotas, Inc. and the Semper Fi Fund Work Together to Provide Pain Relief to Injured Service Members 2BioPhotas, Inc. and the Semper Fi Fund Work Together to Provide Pain Relief to Injured Service Members 3Sanomedics to Showcase the Caregiver at National Association of Pediatric Nurse Practitioners Conference 2Sanomedics to Showcase the Caregiver at National Association of Pediatric Nurse Practitioners Conference 3
    ... Corporation (NYSE: CVS ) today announced that ... making a presentation to investors at the Sanford C. ... Merlo is scheduled to present at 2:00 pm EDT. ... of the presentation will be broadcast simultaneously through the ...
    ... BANNOCKBURN, Ill., May 20, 2011 Omron Healthcare, Inc., the ... pressure category, announced today its donation of 300 blood pressure ... Hypertension (ASH). The donation will be used by ASH to ... all New York boroughs, Long Island and northern New Jersey. ...
    Cached Medicine Technology:Omron Healthcare Announces Donation to the American Society of Hypertension, Inc. 2
    (Date:3/6/2015)... CHICAGO (PRWEB) March 06, 2015 As ... and healthcare services programs, the organization has hired two ... Hagerty, Ph.D. They will report to Grace Pavlath, ... Vice President and Scientific Program Director, and together will ... lead to treatments and cures for various types of ...
    (Date:3/6/2015)... Parents need to start the discourse ... use disorders. School programs like DARE, or Drug Abuse ... or Narcotics Overdose Prevention and Education has already impacted ... News on Feb. 27th. As teens continue to ... drug prevention proponents are lobbying Florida to pass The ...
    (Date:3/6/2015)... Anaheim, Cailfornia (PRWEB) March 06, 2015 ... lifestyle technology company, announced today the launch of ... save money on healthy and sustainable products at ... retailers. Makeena is exhibiting at Expo West Booth ... to search by gluten-free, Kosher, non-GMO, organic, Paleo, ...
    (Date:3/6/2015)... 06, 2015 Since Medicare began paying ... there has been an overwhelming demand from providers for ... compliant CCM program. The Centers for Medicare & ... , PYA’s updated white paper—“ Providing and Billing ... into a detailed, yet practical “how to” manual for ...
    (Date:3/6/2015)... Atlanta, GA (PRWEB) March 06, 2015 ... algorithms, announced the release of a Clostridium Difficile ... outpatient providers. The C Diff use case is ... capabilities that span hospital acquired infections, chronic conditions, ... phenotype platform, the C Diff solution flags at ...
    Breaking Medicine News(10 mins):Health News:MDA Adds Muscle Disease and ALS Leaders to Research Team 2Health News:MDA Adds Muscle Disease and ALS Leaders to Research Team 3Health News:MDA Adds Muscle Disease and ALS Leaders to Research Team 4Health News:A Harbor Village Detox Clinical Psychologist Encourages School Programs like NOPE to Positively Impact Awareness of Substance Use Disorders 2Health News:Makeena Launches App that Makes Healthy and Sustainable Products More Affordable for Shoppers 2Health News:Makeena Launches App that Makes Healthy and Sustainable Products More Affordable for Shoppers 3Health News:Updated PYA White Paper Meets Demand for Guidance on Providing and Billing Medicare for Chronic Care Management 2Health News:Jvion Predicts Patients at Risk of C Difficile Infection to Reduce Risk and Save Lives 2
    ... The bottom-line message from a decades-long study of monkeys ... leads to a longer, healthier life. Writing today ... team of researchers at the University of Wisconsin-Madison, the ... Middleton Memorial Veterans Hospital reports that a nutritious but ...
    ... July 9 Connectyx (Other OTC: CTYX) - Connectyx Technologies ... hosting a Nationwide Teleconference today, July 9, 2009, at 4:15pm ... Schuman, Connectyx President and CEO will update shareholders and the ... Company has developed over the last six months, its initiatives ...
    ... 9 Emergency information is just one touch away with ... application for the Apple iPhone. , , This is ... to review first aid procedures, anytime, anywhere. First aid instructions ... , Powered by Jive Media, the application is available for ...
    ... Echo Therapeutics, Inc. (OTC Bulletin Board: ECTE), ... tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring ... M.D., Chairman and Chief Executive Officer, will present at the ... 5:30 pm ET. The presentation will occur live and ...
    ... to grow in popularity, injuries to soccer players are ... into gender-based patterns and new research at Hospital for ... lead to better treatment, or even prevention for present ... year,s American Orthopaedic Society for Sports Medicine meeting in ...
    ... Ga., July 9 Immucor, Inc. (Nasdaq: BLUD ... the blood transfusion industry, today announced that it will release ... after the market close. The Company will host a conference ... time) to discuss the results. , , ...
    Cached Medicine News:Health News:Reduced diet thwarts aging, disease in monkeys 2Health News:Reduced diet thwarts aging, disease in monkeys 3Health News:Connectyx Technologies Holdings Group, Inc. to Host Nationwide Teleconference Today, July 9, 2009; Company Will Discuss Recent Developments, New Partnerships and Initiatives for MedFlash EPHR, and Second Quarter Results 2Health News:American Heart Association Launches First iPhone Application: First Aid and CPR Information Within Pocket's Reach 2Health News:Echo Therapeutics To Present at Prestigious 'Innovations in Diabetes' Conference 2Health News:Echo Therapeutics To Present at Prestigious 'Innovations in Diabetes' Conference 3Health News:Motion analysis helps soccer players get their kicks 2Health News:Motion analysis helps soccer players get their kicks 3
    ... Chrono-log's wide range of Platelet aggregometers ... to meet particular needs. Single, dual ... with chart recorder outputs or digital ... Chrono-log Optical aggregometers, which measure platelet ...
    ... a four channel platelet aggregation profiler combined ... in conjunction with Microsoft WindowsTM, the PAP-4CD ... tests, automatic storage of test results, plus ... test modes are available: chromogenic assays, von ...
    ... is a four channel platelet aggregation profiler ... assays, von Willebrand assay (Ristocetin cofactor), platelet ... also be used for the evaluation and ... channels allow four tests to be run ...
    ... plus, innovation means 4 on-board measurement ... and im-proved operator ergonomics. This supports ... required for true workload consolidation, leading ... only one analytical platform, one user ...
    Medicine Products: